NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/16/2026
Back to search
Official data from USPTO
C
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
07/16/2026
Trademark type
Combined
Nice classes
5, 10, 35, 42
Filing date
04/02/2021
Registration date
08/02/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/02/2022
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
IT
Examiner
WELLS, KELLEY L
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists a hexagon shape consisting on the left side of a letter "C" in pantone cool gray 4 C and on the right side of the stylized representation of an anchor formed by a circle and a right pointing arrow in fuchsia pantone 227 C.
Holders and representatives
Holders
CHIESI FARMACEUTICI S.P.A.
Representatives
Reed Fryar Vorys, Sater, Seymour and Pease LLP
Technical classification
Nice Classes
Class 5Class 10Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of diseases of the respiratory systemcentral nervous system CNSthe metabolic systemthe cardio-vascular systemthe musculo-skeletal systemimmune systemgastro-intestinal systemendocrine systemcaused by bacteria; Pharmaceuticals for the treatment of autoimmune disordersviral diseasesskin diseases; pharmaceuticals and natural remedies for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; pharmaceutical compositions for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; medicines for human purposes for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; medicinal healthcare preparations for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; medicinal preparations and substances for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; biotechnological preparations for medical use for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; stem cells for medical purposes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; medicinal infusions for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; medicated compresses; preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for the treatment of central nervous system CNS diseases; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of disorders caused by bacteria; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations for ophthalmological use; pharmaceutical products for ophthalmological use; medicated plasters; transdermal patches for the treatment of diseases of the musculo-skeletal system; transdermal patches for medical treatment of the musculo-skeletal system diseases; liquid vitamin supplements; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; nutraceuticals for use as a dietary supplement; vitamin preparations in the nature of food supplements; dietary supplements consisting of vitamins; nutraceuticals for therapeutic purposes for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; enzyme dietary supplements; vitamin and mineral supplements; disinfectants and antiseptics; viral vaccines
Class 10
medical apparatus and instruments for treating cardiovascular diseasefor treating osteoarthritisfor monitoring blood oxygen saturationblood gas concentrationsvital signs and respiratory events; apparatus for administering pharmaceuticalsmedical devices for accessing subcutaneous structures of the human body; apparatus for administering drugs by inhalation sold empty; medical ventilators; oxygen inhalators for therapeutic purposes sold empty; infusion pumps to deliver medication; respiratory therapy instrumentssterile disposable oxygen humidifiers and nebulizers for respiratory therapy sold pre-filled with water; medical apparatus for assisting breathingportable devices used for breathing exercises and for respiratory muscle training; portable nebulisers for medical purposes; ventilator breathing apparatus for artificial respiration; medical apparatus for the treatment of respiratory conditionsinfusion and injection devices for delivering pharmaceuticals and solutionsoxygen inhalatorsinfusion pumpsportable nebulisers for medical purposesall sold emptymedical apparatus for the treatment of respiratory conditionsinfusion and injection devices for delivering pharmaceuticals and solutionsoxygen inhalatorsinfusion pumpsportable nebulisers for medical purposesall sold empty; respiratory masks for medical purposes; inhalers for medical usesold empty; nebulizers for respiration therapy; respirators for artificial respiration for medical purposes; apparatus for the alleviation of breathing difficultiesinfusion and injection devices; masks and equipment for artificial respiration; oxygenators for medical use; medical apparatus for facilitating the inhalation of pharmaceutical preparationssold empty; vaporizers for the treatment of upper respiratory conditions; oxygen inhalers for medical use sold empty; diagnosticexamination and monitoring equipmentequipment for monitoring blood oxygen saturationblood gas concentrationsvital signs and respiratory events; surgical ophthalmic instruments; massage apparatus; dummies for babies; catheters for medical use; apparatus for the regeneration of stem cells for medical purposes; implantable subcutaneous drug delivery devices; prostheticsligaments and tissues for vascular use and artificial implant; artificial limbs; orthopedic articlesdevices used in orthopedic transplant and/or implant surgery; orthopedic joint implants made of artificial materials; sphygmotensiometers; equipment for diagnosisexaminations and monitoringequipment for monitoring blood oxygen saturationblood gas concentrationsvital signs and respiratory events
Class 35
Promotional and advertising services; advertising services relating to pharmaceutical products; advertising services to promote public awareness of medical issues; advertising services to promote public awareness of medical conditions; advertising services relating to cosmetics; providing consumer product information relating to cosmetics; retail store services in relation to dietetic preparations; retail store services in relation to pharmaceutical preparations; online retail store services in relation to cosmetics; retail store services in relation to medical instruments; retail store services in relation to medical apparatus; retail store services for a pharmaceuticalveterinary and sanitary preparations and medical supplies
Class 42
Scientific and technology servicespharmaceutical drug development services; technological research services in the field of pharmaceutical research and development; scientific research in the field of pharmacy; scientific research relating to biology; scientific research relating to genetics; scientific research and industrial research in the field of pharmaceutical research and development; scientific research and analysispharmaceutical research and development; scientific and technological services relating to pharmaceutical drug and nutritional supplements development; medical and pharmacological research services; providing scientific information in the field of medical disorders and their treatment; development of pharmaceutical preparations and medicines; research and development in the pharmaceutical and biotechnology fields; bacteriological research and analysis; biological research and analysis; chemical research and analysis services; clinical researchconducting clinical trials for others; biological researchclinical research in the field of respiratory science and medicine and medical research; industrial analysis and research services in the field of pharmaceutical research; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells
Publications
History of USPTO decisions and trademark events.
32 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/17/2022
FIMP
FINAL DISPOSITION PROCESSED
11/16/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/02/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/17/2022
PUBO
PUBLISHED FOR OPPOSITION
05/17/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/16/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/27/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/27/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/14/2022
ALIE
ASSIGNED TO LIE
04/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
04/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
04/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/17/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/16/2022
RFNT
REFUSAL PROCESSED BY IB
01/10/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/22/2021
RFRR
REFUSAL PROCESSED BY MPU
12/22/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/19/2021
CNRT
NON-FINAL ACTION WRITTEN
11/18/2021
DOCK
ASSIGNED TO EXAMINER
11/17/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/14/2021
Continuous trademark protection
Get notified about every new filing that threatens C or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.